gms | German Medical Science

78. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

16.05. - 20.05.2007, München

Development of an assessment scale for the Sino-Nasal Outcome Test-20 German Adapted Version (SNOT-20 GAV)

Meeting Abstract

Suche in Medline nach

  • corresponding author Ingo Baumann - Department of Otolaryngology, University of Heidelberg, Heidelberg, Germany
  • author Harry De Maddalena - Department of Otolaryngology, University of Tübingen, Tübingen, Germany

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. 78th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. Munich, 16.-20.05.2007. Düsseldorf, Köln: German Medical Science; 2007. Doc07hno063

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter:

Veröffentlicht: 8. August 2007

© 2007 Baumann et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.



Introduction: Quality of life measurements in chronic rhinosinusitis (CRS) patients with the Sino-Nasal Outcome Test 20 German Adapted Version (SNOT-20 GAV) require normative values of a comparison group. Thus, conclusions shall be available about the correlation of scores and complaints as well as how far surgically treated patients may reach score levels of healthy subjects.

Patients and Methods: We collected SNOT-20 GAV data and data concerning existence of CRS from 778 subjects via a web-based questioning of employees of the University Hospital of Heidelberg. For comparison we used data of 163 CRS patients that had been operated with endonasal sinus surgery (ESS)

Results and Discussion: Gender and age did not have significant impact on the scores of the SNOT-20 GAV. We defined an assessment scale with four classes regarding intensity of complaints and probability of indication for ESS. Operated patients with CRS showed a persisting small disadvantage in the scales of the SNOT-20 GAV when compared with the comparison subgroup of subjects without CRS. When comparing operated CRS patients with the complete comparison group these disadvantages were only obvious in the scale Primary Nasal Symptoms (PNS) but not in the other scales.

Conclusion: Patients with CRS benefit from ESS and approximate to the scores of the comparison group. The newly developed assessment scale is easy to use and gives the attending physician additional information about the impairment by CRS.